The Metabolic Control of Myeloid Cells in the Tumor Microenvironment
Myeloid cells are a key determinant of tumor progression and patient outcomes in a range of cancers and are therefore being actively pursued as targets of new immunotherapies. The recent use of high-dimensional single-cell approaches, e.g., mass cytometry and single-cell RNA-sequencing (scRNA-seq) h...
Guardado en:
Autores principales: | Eloise Ramel, Sebastian Lillo, Boutaina Daher, Marina Fioleau, Thomas Daubon, Maya Saleh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f57e36c95fc41128b29b93698117b9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
por: Mojdeh Soltani, et al.
Publicado: (2021) -
The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment
por: Maria Iorio, et al.
Publicado: (2021) -
A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia
por: Seyed Mohammadreza Bolandi, et al.
Publicado: (2021) -
Dysregulated Immunometabolism Is Associated with the Generation of Myeloid-Derived Suppressor Cells in Staphylococcus aureus Chronic Infection
por: Oliver Dietrich, et al.
Publicado: (2021) -
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Yaolin Xu, et al.
Publicado: (2021)